Direxion Daily SandP Biotech Bull 3X Shares (LABU) |
132.72 0.29 (0.22%) 03-28 16:00 |
Open: | 133.75 |
High: | 136.5 |
Low: | 128.89 |
Volume: | 2,375,356 |
Market Cap: | 1,239(M) |
PE Ratio: | 0 |
Exchange: | New York Stock Exchange Arca |
Industry: | |
Sector: | Miscellaneous |
Technical analysis | ||||
sell | buy |
Resistance 2: | 176.99 |
Resistance 1: | 156.05 |
Pivot price: | 133.94 |
Support 1: | 122.18 |
Support 2: | 101.65 |
52w High: | 176.99 |
52w Low: | 48.4 |
The fund invests at least 80% of its net assets (plus borrowing for investment purposes) in financial instruments and securities of the index, exchange-traded funds ("ETFs") that track the index and other financial instruments that provide daily leveraged exposure to the index or ETFs that track the index. The index is designed to measure the performance of the biotechnology sub-industry based on the Global Industry Classification Standards ("GICS"). The fund is non-diversified.
EPS | 0.000 |
Book Value | 0.000 |
PEG Ratio | 0.00 |
Gross Profit | 0.000 |
Profit Margin (%) | 0.00 |
Operating Margin (%) | 0.00 |
Return on Assets (ttm) | 0.0 |
Return on Equity (ttm) | 0.0 |
Wed, 06 Mar 2024
5 Biggest Biotechnology ETFs in 2024 - Investing News Network
Tue, 05 Mar 2024
Top Performing Leveraged/Inverse ETFs: 03/03/2024 - ETFdb.com
Mon, 04 Mar 2024
4 Best Inverse/Leveraged ETF Areas of Last Week - Yahoo Finance
Sun, 03 Mar 2024
LABU: A Really Bad Drift - Seeking Alpha
Fri, 01 Mar 2024
5 Best-Performing Leveraged ETFs of February - Zacks Investment Research
Wed, 27 Dec 2023
5 Leveraged ETFs That Are Up More Than 50% in December - Yahoo Finance
StockChart iOS |
StoxlineLite iOS |
StoxlineLite iOS |
OptionCalc iOS |
StockChart Android |
StoxlineLite Android |
StoxlinePro Android |
OptionCalc Android |